Tag: Eli Lilly

In a move that sent shockwaves through the market, global banking giant HSBC has downgraded its stance on Eli Lilly ...

To address overwhelming global demand for its blockbuster diabetes and weight-loss treatments, Eli Lilly and Company is embarking on another ...

Pharmaceutical leader Eli Lilly continues to solidify its position in the weight-loss medication sector. The company is benefiting from a ...

Pharmaceutical giant Eli Lilly issued a significant public safety alert on March 12, 2026, concerning chemically contaminated compounded versions of ...

Pharmaceutical giant Eli Lilly is making a substantial long-term commitment to China, targeting the nation as its next major growth ...

The pharmaceutical sector is bracing for potential margin compression after Novo Nordisk signaled aggressive price reductions for its blockbuster GLP-1 ...

For months, Eli Lilly has been the undisputed leader in the lucrative market for obesity and diabetes treatments, with its ...

While demand for weight-loss medications remains robust, inconsistent insurance coverage continues to be a significant barrier for many patients. Pharmaceutical ...

Eli Lilly has provided a more definitive timeline for one of its most anticipated pipeline assets. During a presentation at ...

Investors in Eli Lilly have received two distinct but significant pieces of news this week, highlighting the pharmaceutical giant's growth ...